New Micropeptins with Anti-Neuroinflammatory Activity Isolated from a Cyanobacterial Bloom

Area of Science:

• Natural Product Chemistry
• Marine Microbiology
• Neuropharmacology

Background:

• Aquatic and marine microbiomes are rich sources of novel therapeutic compounds.
• Metabolite mining provides a pathway for discovering lead molecules for drug development.
• Cyanobacterial peptides have shown environmental significance and potential therapeutic applications.

Purpose of the Study:

• To discover and characterize new micropeptins from environmental samples.
• To evaluate the anti-neuroinflammatory potential of isolated metabolites.
• To demonstrate the utility of natural product libraries for identifying therapeutic leads.

Main Methods:

• Utilized a prefractionated chromatography library.
• Employed liquid chromatography tandem mass spectrometry (LC-MS/MS) for molecular networking.
• Conducted biological assays using BV-2 mouse microglial cells to assess anti-neuroinflammatory activity.

Main Results:

• Isolated and characterized two new micropeptins (1 and 2) and micropeptin 996.
• Demonstrated potent anti-neuroinflammatory activity of the isolated metabolites.
• Achieved a 50% reduction in inflammation at concentrations ranging from 1 to 10 μM.

Conclusions:

• Cyanobacterial peptides hold significant promise for therapeutic applications beyond their environmental impact.
• Large, prefractionated natural product libraries are valuable for hit and lead identification in drug discovery.
• This study highlights the potential of marine microbial metabolites in combating neuroinflammation.